In this episode, Hall T. Martin conducts an interview with Randy Goldsmith, founder and director of Rapamycin Holdings. Rapamycin Holdings is a San Antonio-based company that is developing and commercializing a patented oral formulation of Rapamycin for the prevention of cancer progression and recurrence. Hall and Randy discuss his background in the industry. They also discuss the FDA process and challenges as well as measuring progress.

Copyright (c) 2024, Hall Martin and investorconnect.org. All rights reserved.

Disclaimer:
Hall T Martin is the director of Investor Connect, which is a 501(c)(3) nonprofit dedicated to the education of investors for early-stage funding. All opinions expressed by Hall and podcast guests are solely their own opinions and do not reflect the opinion of Investor Connect. This podcast is for informational purposes only and should not be relied upon for the basis of investment decisions.